Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer

被引:9
|
作者
Okita, Kazutaka [1 ]
Hatakeyama, Shingo [1 ]
Fujita, Naoki [1 ]
Konishi, Sakae [1 ]
Yamamoto, Hayato [1 ]
Imai, Atsushi [1 ]
Yoneyama, Takahiro [1 ]
Hashimoto, Yasuhiro [1 ]
Ito, Hiroyuki [2 ]
Yoshikawa, Kazuaki [3 ]
Koie, Takuya [4 ]
Ohyama, Chikara [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifu Chou, Hirosaki, Aomori 0368562, Japan
[2] Aomori Rosai Hosp, Dept Urol, Hachinohe, Aomori, Japan
[3] Mutsu Gen Hosp, Dept Urol, Mutsu, Aomori, Japan
[4] Gifu Univ, Dept Urol, Grad Sch Med, Hirosaki, Aomori, Japan
基金
日本学术振兴会;
关键词
Cystectomy; Weight loss; Frailty; Survival; Bladder cancer; OUTCOMES; EXPERIENCE;
D O I
10.1007/s12032-018-1232-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to investigate the impact of postoperative weight loss following radical cystectomy (RC) on patients' prognoses. RC and urinary diversion were performed in 512 consecutive patients with muscle-invasive bladder cancer at our hospitals between May 1996 and July 2018. Demographic clinical information, pre- and postoperative serum albumin, hemoglobin, and weight were evaluated retrospectively at 1month. We also evaluated the association of weight loss with complications and overall survival (OS) as estimated using the Kaplan-Meier method and compared using the log-rank test. Risk factors for poor OS were determined by Inverse Probability of Treatment Weighted (IPTW)-adjusted Cox regression analysis. In 385 patients who met the study search criteria, median postoperative weight loss from baseline at 1week and 1month was 1.1 (-1.8%) and 3.2 (-5.4%) kg, respectively. Patients with significant weight loss (defined as 7.5% at 1month) had higher-grade complications within 1month and had significantly shorter OS than those with weight loss of <7.5%. Type of urinary diversion, loss of serum albumin, and loss of hemoglobin were not significantly associated with weight loss. IPTW-adjusted Cox regression analysis showed that such significant weight loss was an independent risk factor for poor OS. Weight loss followed by radical cystectomy was significantly associated with poor prognosis in patients with muscle-invasive bladder cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy
    Salama, Asmaa
    Abdelmaksoud, Abdelmaksoud M.
    Shawki, Ashraf
    Abdelbary, Ahmad
    Aboulkassem, Hatem
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : E43 - E47
  • [32] Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer
    Li, Bin
    Guo, Li-hua
    Ban, Zi-qin
    Liu, Lu
    Luo, Lei
    Cui, Tong-yue
    MEDICINE, 2020, 99 (28) : E21059
  • [33] Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
    Zhong, Jim
    Switchenko, Jeffrey
    Jegadeesh, Naresh K.
    Cassidy, Richard J.
    Gillespie, Theresa W.
    Master, Viraj
    Nieh, Peter
    Alemozaffar, Mehrdad
    Kucuk, Omer
    Carthon, Bradley
    Filson, Christopher P.
    Bilen, Mehmet A.
    Jani, Ashesh B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (01): : 36 - 41
  • [34] Alternatives to cystectomy in muscle-invasive bladder cancer
    Goel, S
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 3003 - 3003
  • [35] Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis
    Koie, Takuya
    Okamoto, Teppei
    Suzuki, Yuichiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Yamamoto, Hayato
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Kamimura, Noritaka
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [36] NEOADJUVANT GEMCITABINE PLUS CARBOPLATIN FOLLOWED BY IMMEDIATE RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A PROPENSITY SCORE ANALYSIS
    Koie, Takuya
    Okamoto, Akiko
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2012, 187 (04): : E217 - E218
  • [37] Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis
    Koie, T.
    Okamoto, T.
    Suzuki, Y.
    Tobisawa, Y.
    Yoneyama, T.
    Mori, K.
    Yamamoto, H.
    Hatakeyama, S.
    Kudoh, S.
    Yoneyama, T.
    Kamimura, N.
    Ohyama, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E867 - U826
  • [38] Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer
    Pierre-Louis Reignier
    Hélène Gauthier
    Christophe Hennequin
    Quiterie Aussedat
    Evanguelos Xylinas
    François Desgrandchamps
    Stéphane Culine
    Alexandra Masson-Lecomte
    Clément Dumont
    World Journal of Urology, 2023, 41 : 3249 - 3255
  • [39] Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer
    Reignier, Pierre-Louis
    Gauthier, Helene
    Hennequin, Christophe
    Aussedat, Quiterie
    Xylinas, Evanguelos
    Desgrandchamps, Francois
    Culine, Stephane
    Masson-Lecomte, Alexandra
    Dumont, Clement
    WORLD JOURNAL OF UROLOGY, 2023, 41 (11) : 3249 - 3255
  • [40] Comparing Prognosis Associated with Partial Cystectomy and Trimodal Therapy for Muscle-Invasive Bladder Cancer Patients
    Su, Quanxin
    Gao, Shenglin
    Lu, Chao
    Wu, Xingyu
    Zuo, Li
    Zhang, Lifeng
    UROLOGIA INTERNATIONALIS, 2023, 107 (01) : 46 - 57